The Leadership Team at Biohaven Pharmaceuticals is responsible for setting the strategic direction and oversight of the company’s research and development initiatives focused on the glutamatergic system. Comprising top executives from various disciplines, including R&D, medical affairs, and commercial strategy, the team collaborates to drive innovative drug development, ensure regulatory compliance, and establish partnerships that enhance the company's market position and growth potential. Their efforts are crucial in advancing clinical programs and bringing novel therapies to patients suffering from neurological disorders.
Cliff Bechtold
President & GM, Biohaven Irela...
Elyse Stock
Senior Scientific Advisor
Irfan Qureshi
VP, Neurology
John Tilton
Chief Commercial Officer
Kimberly Gentile
SVP, Clinical Operations
Marianne Frost
SVP, Regulatory Affairs
Rajesh Kumar
SVP, Global CMC & Supply Chain
Robert Croop
Chief Development Officer, Neu...
St John Donnie McGra...
Chief of Corporate Strategy & ...
William Jones
Chief Commercial Officer, Migr...
View all